Targeting messengerRNAs with LNA-based drugs

messengerRNAs carry information from the genomic to be translated into proteins that determine all aspects of cell identity and behavior, including disease.

Much is known about this class of RNAs and Santaris Pharma a/s and its partners are building a strong and diversified pipeline of LNA drugs against a number of such messengerRNA-targets for the treatment of diseases with significant unmet medical needs.